Primary Antibodies

Immunogen lipocalin 15 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry. The

Immunogen lactase-like Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry. The

Immunogen low density lipoprotein receptor adaptor protein 1 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive

Ligand-dependent nuclear receptor-interacting factor 1 (LRIF1), also known as RIF1, Receptor-interacting factor 1, and is encoded by the gene LRIF1/C1orf103/RIF1. The retinoic acid receptors (RARs) are ligand-dependent transcription factors that

Lin28 is a developmentally regulated RNA binding protein (RBP). It&#8217s down regulation is mediated in part by Lin4 and miR-125b, the mammalian micro-RNA homolog of Lin4.

Immunogen synthetic peptide corresponding to amino acids 328-344 of human EDG-2/LPA 1 . Application Anti-LPA 1 , C-Terminal antibody produced in rabbit is suitable for western blotting at a working dilution of 1:1000 using rat brain microsomal

Immunogen 1-acylglycerophosphocholine O-acyltransferase 1 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as

Immunogen 1-acylglycerophosphocholine O-acyltransferase 1 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies &#174 Powered by Atlas Antibodies is developed and validated by the Human Protein Atlas (HPA) project .

LRFN4 is one of a family of five transmembrane glycoproteins that are highly expressed in neuronal tissues. LRFN proteins share leucine-rich repeat (LRR)-immunoglobulin-like (Ig)-fibronectin type III (Fn)-transmembrane domain structure with other

Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1), also known as GC-binding factor 2 or TAR RNA-interacting protein, and encoded by the gene name LRRFIP1 or GCF2 or TRIP, is a transcriptional repressor that

Specificity Recognizes LRRK2 (leucine-rich repeat kinase 2, Dardarin) Immunogen Synthetic peptide from human LRRK2. Application Detect LRRK2 using this ANTI-LRRK2 Antibody validated for use in IH.

LRRK2 (Leucine-rich repeat serine/threonine-protein kinase 2) is a multifunctional protein belonging to the ROCO family of proteins. LRRK2 contains multiple domains including a ROC (Ras of Complex protein) domain that binds and hydrolyzes GTP, and